State Street Corp Albireo Pharma, Inc. Transaction History

State Street Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.0 - $44.95 $0 - $15.6 Million	-348,114 Closed	0 $0
Q4 2022 Feb 14, 2023	SELL	$18.01 - $23.78 $43,764 - $57,785	-2,430 Reduced 0.69%	348,114 $7.52 Million
Q3 2022 Nov 15, 2022	SELL	$16.32 - $26.37 $17.5 Million - $28.3 Million	-1,073,799 Reduced 75.39%	350,544 $6.79 Million
Q2 2022 Aug 15, 2022	BUY	$18.54 - $37.29 $9.56 Million - $19.2 Million	515,615 Added 56.74%	1,424,343 $28.3 Million
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $2.01 Million - $2.84 Million	-84,104 Reduced 8.47%	908,728 $27.1 Million
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $1.32 Million - $1.94 Million	-62,079 Reduced 5.88%	992,832 $23.1 Million
Q3 2021 Nov 15, 2021	BUY	$27.36 - $35.98 $5.73 Million - $7.54 Million	209,428 Added 24.77%	1,054,911 $32.9 Million
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $4.51 Million - $5.76 Million	-156,177 Reduced 15.59%	845,483 $29.7 Million
Q1 2021 May 17, 2021	BUY	$32.03 - $42.85 $7.04 Million - $9.42 Million	219,895 Added 28.13%	1,001,660 $35.3 Million
Q4 2020 Feb 16, 2021	BUY	$31.56 - $42.16 $17.6 Million - $23.5 Million	558,117 Added 249.55%	781,765 $29.3 Million
Q3 2020 Nov 10, 2020	SELL	$23.19 - $41.61 $69,013 - $123,831	-2,976 Reduced 1.31%	223,648 $7.46 Million
Q2 2020 Aug 14, 2020	BUY	$14.82 - $29.92 $99,427 - $200,733	6,709 Added 3.05%	226,624 $6 Million
Q1 2020 May 11, 2020	BUY	$11.67 - $27.23 $2.57 Million - $5.99 Million	219,915 New	219,915 $3.6 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.